Fusion Pharmaceuticals Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $1.95M, a 253% increase year-over-year.
  • Fusion Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $6.52M.
  • Fusion Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was $5.12M.
  • Fusion Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was -$1.42M, a 266% decline from 2021.
  • Fusion Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2021 was $850K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.52M $1.95M +$1.4M +253% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.12M $1.39M +$1.93M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $3.19M $1.88M +$2.85M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $337K $1.29M +$1.76M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$1.42M $553K -$8K -1.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$1.42M -$540K -$684K -475% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$731K -$969K -$1.1M -823% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $372K -$467K -$895K -209% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.27M $561K +$417K +290% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $850K $144K -$654K -82% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.5M $134K -$7K -4.97% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.51M $428K +$37.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$36.2M $144K +$1.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$37.8M $798K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $141K -$3.61M -96.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$37.3M -$37.7M -8030% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$1.46M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $3.75M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $470K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.